Alto Ingredients sets up up to $50 million at-the-market stock sale program
Alto Ingredients entered an at-the-market sales agreement on August 5, 2026, allowing it to sell up to $50.0 million of common stock through three sales agents over time. The company is not obligated to sell any shares, and any sales would add to the outstanding share count, which could dilute existing shareholders.
Key points
- Program covers up to $50.0 million of common stock at an aggregate offering price, sold through Craig-Hallum Capital Group LLC, The Benchmark Company, LLC and H.C. Wainwright & Co., LLC
- Company pays the agents a 3.0% commission on aggregate gross proceeds, plus certain expenses
- Shares are issued under a Form S-3 shelf registration declared effective May 22, 2026, with a prospectus supplement filed August 5, 2026
- Net proceeds, if any, are intended for general corporate purposes, including working capital and capital expenditures
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.